Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-28T02:16:14.389Z Has data issue: false hasContentIssue false
  • English
  • Français

Lamictal

Published online by Cambridge University Press:  18 September 2015

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Index
Information
Canadian Journal of Neurological Sciences , Volume 24 , Issue 1 , February 1997 , pp. xxviii - xxix
Copyright
Copyright © Canadian Neurological Sciences Federation 1977

References

References:

1. Goa, KL el al. Lamotrigine: A review of its pharmacological properties and dinical efficacy in epilepsy. Drugs 1993;46(1):152–176.Google Scholar
2. Leach, MJ et al. Neurochemical and behavkxal aspects of lamotrigine. Epilepsia 1991;32(Suppl.2):S4–S8.CrossRefGoogle ScholarPubMed
3. Data on file Glaxo Wellcome (GWMN[2]:09/96).Google Scholar
4. Brodie, MJ Lamotrigine versus other antiepileptic drugs: A star rating system is born. Epilepsia 1994;35(Suppl.5):S41–46.Google Scholar
5. Product Monograph of LAMICTAL, Nov. 1994.Google Scholar
6. Richens, A, Yuen, AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 1991;32(Suppl.2):S13–S16.Google Scholar
7. Betts, T et al. Human safety of lamotrigine. Epilepsia 1991;32(Suppl.2):S17–S21.Google Scholar
8. Binnie, CD et al. Acute effects of lamotrigine (BW 430C) in persons with epilepsy. Epilepsia 1986;27(3)248–254.Google Scholar
9. Sander, JWAS et al A randomised double-blind placebo-controlled add-on trial of lamtrigine in patients with severe epilepsy. Epilepsy Res 1990;6(3):221–226.Google Scholar
10. Yuen, AWC Lamotrigine: A review of antiepileptic efficacy. Epilepsia 1994;35(Suppl.5):S33–S3.CrossRefGoogle ScholarPubMed
11. Binne, CD Lamotrigine. Comprehensive Epleptology. New York Raven Press 1990:665–670.Google Scholar
12. Binne, CD et al. Double-blind crossover tiral of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989;4(3)222–229.Google Scholar
13. Dren, AT et al Placebo-controlled, dose-response evaluation of the efficacy and safety of motrigine (LAMICTA) as add-on therapy in epileptic outpatients with partial seizures. Epilepsia 1991:32 (Suppl.3)2.Google Scholar
14. Gay, PE et al. Chronic dose tolerance of lamotrigine and placebo in patients with epilepsy. Epilepsia 1988;29(5):686.Google Scholar
15. Jawad, S et al. Controlled trial of lamotrigiie (Lamictal) for refractory partial seizures. Epilepsia 1989;30(3):356–363.CrossRefGoogle ScholarPubMed
16. Loiseau, P et al. A randomised double-bilnd placebo-controlled crossover add-on trial of lamotrigine it patient with trealment-resistant partial seizures. Epilepsy fles 1990;7(2):136–145.Google Scholar
17. Matsuo, F et al. Placebo-controled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 1993;43:2284–2291.Google Scholar
18. Messenheimer, J et al. Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial. Epilepsia 1994;35(1):113–121.Google Scholar
19. Mikati, MA et al. Long-term tolerability, pharmacokinetic and preliminary efficacy study of Lamotrigine in patients with resistant partial seizures. Neuropharmacol 1989;12(4):312–321.Google Scholar
20. Miller, AA et al. Lamotrigine. New Anticonvulsant Drugs 1986; 165–177.Google Scholar
21. Risner, ME et al. Multicenter, double-blind, placebo-controlled, add-on, crossover study of lamotrigine (Lamictal) in epileptic outpatients with partial seizures. Epilepsia 1990;31(5):619–620.Google Scholar
22. Schapel, GJ et al. No effect of lamotrigine on carbamazepine and mazepine-epoxide concentrations. Epilepsia 1991;32 (Suppl.1):58.Google Scholar
23. Smith, D et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34(2);312–322.Google Scholar
24. Betts, T Clinical use of lamotrigine. Seizure 1992;1:3–6.Google Scholar
25. Binnie, CD. The efficacy of lamotrigine. Rev Contemp Pharmacother 1994;5:115–122.Google Scholar
26. Cohen, AF et al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;20:619–629.Google Scholar